FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On September 27, 2005
Table of Contents
Docket # Title
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003P-0064 Withhold Approval of Generic Lovenox (enoxaparin sodium inje
2003P-0574 Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
2004D-0333 Emergency Use Authorization of Medical Products
2004D-0369 Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
2004H-0322 Civil Money Penalty Re: Ecumed Health Group, Inc.
2005M-0378 P930014/S015 - ACRYSOF Toric Posterior Chamber Intraocular Lens, Approved 9/14/05
2005M-0379 P040037 - GORE VIABAHN Endoprosthesis, Approved 6/14/05
2005M-0380 P030036 - SelectSecure Lead Model 3830, Approved 8/3/05
2005M-0381 P040038 - Xact Carotid Stent System, Approved 9/6/05
2005M-0382 P930016/S021 - STAR S4 IR Excimer Laser System with Variable Spot Scanning (VSS) and WaveScan WaveFront System, Approved 8/30/05
2005M-0387 P040005 - DakoCytomation Her2 FISH pharmDx Kit, Approved 5/3/05
2005M-0388 P040011 - DakoCytomation c-Kit pharmDx, Approved 6/27/05
2005N-0279 Food Labeling; Gluten-Free Labeling of Foods; Public Meeting
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
2005P-0139 withdrawal of approvals of certain herdwide/flockwide uses of critically and highly important antibiotics pursuant to guidance #152
2005P-0267 Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
2005P-0325 Request Commissioner of Food and Drugs to amend its regulations related to sugar and alternative sweeteners
2005P-0398 ANDA Suitability for Carboplatin Injection, 10 mg/mL in a 1000 mg/100 mL multiple-dose vial
2005P-0400 permission to Donna Ricks to contine using Palladone for severe chronic pain due to stage 4 metastic breast cancer
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
EMC 1286 L Fenton Vol #: 6
EMC 1287 K Paul Vol #: 6
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 1120 J Perrey Vol #: 11
EMC 1121 E Limas Vol #: 11
2003P-0064 Withhold Approval of Generic Lovenox (enoxaparin sodium inje
SUP 2 Aventis Pharmaceuticals, Inc. Vol #: 3
2003P-0574 Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
C 12 Center for Science in the Public Interest Vol #: 2
2004D-0333 Emergency Use Authorization of Medical Products
C 4 Elusys Therapeutics Inc Vol #: 1
2004D-0369 Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
EMC 1565 M Burns Vol #: 22
2004H-0322 Civil Money Penalty Re: Ecumed Health Group, Inc.
CS 16 HFA-305 Vol #: 2
LET 6 Ecumed Health Group and Amador Reyes, et al Vol #: 2
LET 7 Ecumed Health Group andJuan C. Carrai , et al Vol #: 2
LET 8 GCF-1 to Ecumed Group and Amador Reyes, Juan C. Carrai, and Richard W. Stone, M.D. Vol #: 2
OR 15 HF-3 to Ecumed Health Group, and Amador Reyes, Juan C. Carrai, and Richard W. Stone, M.D. Vol #: 2
2005M-0378 P930014/S015 - ACRYSOF Toric Posterior Chamber Intraocular Lens, Approved 9/14/05
AAV 1 Alcon Research Ltd. Vol #: 1
2005M-0379 P040037 - GORE VIABAHN Endoprosthesis, Approved 6/14/05
AAV 1 W.L. Gore & Associates, Inc. Vol #: 1
2005M-0380 P030036 - SelectSecure Lead Model 3830, Approved 8/3/05
AAV 1 Medtronic, Inc. Vol #: 1
2005M-0381 P040038 - Xact Carotid Stent System, Approved 9/6/05
AAV 1 Abbott Vascular Devices Vol #: 1
2005M-0382 P930016/S021 - STAR S4 IR Excimer Laser System with Variable Spot Scanning (VSS) and WaveScan WaveFront System, Approved 8/30/05
AAV 1 VISX, Inc. Vol #: 1
2005M-0387 P040005 - DakoCytomation Her2 FISH pharmDx Kit, Approved 5/3/05
AAV 1 DakoCytomation Denmark A/S Vol #: 1
2005M-0388 P040011 - DakoCytomation c-Kit pharmDx, Approved 6/27/05
AAV 1 DakoCytomation California, Inc. Vol #: 1
2005N-0279 Food Labeling; Gluten-Free Labeling of Foods; Public Meeting
C 632 No Signature Vol #: 22
C 633 S Smith Vol #: 22
C 634 C Crocker Vol #: 22
C 635 M Gardenswartz Vol #: 22
C 636 H Zeiner Vol #: 22
C 637 G Christensen Vol #: 22
C 638 I Horabowy Vol #: 22
C 639 T E Post Vol #: 22
C 640 K McQuillan Vol #: 22
C 641 C Parsons Vol #: 22
C 642 K Walsh Vol #: 22
C 643 A M Lipper Vol #: 22
C 644 S G Verway Vol #: 22
C 645 F Tangredi Vol #: 22
C 646 J C Johnson Vol #: 22
C 647 G Stowe Vol #: 22
C 648 S Asan Vol #: 22
C 649 B H Vaughn Vol #: 22
C 650 H L Scott Vol #: 22
C 651 K Tabershaw Vol #: 22
C 652 N G Cooper Vol #: 22
C 653 D E Eaton Vol #: 22
C 654 No Submitter Vol #: 22
C 655 E G Lebo Vol #: 22
C 656 R Moreland Vol #: 22
C 657 K David Vol #: 22
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
C 11 C Huntley Vol #: 1
C 12 L Squarzini Vol #: 12
C 13 V J Albertazzi Vol #: 1
C 14 Pregnancy Center East Inc Vol #: 1
C 15 M G Watts Vol #: 1
C 16 J E Hy Vol #: 1
C 17 B Stone Vol #: 1
C 18 P A Johnson Vol #: 1
C 19 E Wright Vol #: 1
C 20 JBL Systems Vol #: 1
EC 472 Mr. Roger Lands Vol #: 2
EC 473 Mr. Richard Duguay Vol #: 2
EC 474 Ms. Amy Holt Vol #: 2
EC 475 None Vol #: 2
EC 476 Unitarian Universalist Church West Vol #: 2
EC 477 Ms. Mary Brewington Vol #: 2
EC 478 Dr. Jonathan Schaffir Vol #: 2
EC 479 Dr. Eduardo Lara-Torre Vol #: 2
EC 480 Mrs. Shandra Emrich Vol #: 2
EC 481 Dr. Jolanda Sallmann Vol #: 2
EC 482 Ms. s Nelson Vol #: 2
EC 483 Mrs. Rosa Soulier Vol #: 2
EC 484 Dr. bruce krawisz Vol #: 2
EC 485 Behavior Analyst/Consultant Prviate Vol #: 2
EC 486 Mrs. Carolyn Dressler Vol #: 2
EC 487 United Community Health Centers Vol #: 2
EC 488 parent Vol #: 2
EC 489 Dr. Fernando Cuenca Vol #: 2
EC 490 Mr. Jeff Terhune Vol #: 2
EC 491 Mr. THOMAS KOZLOVSKY Vol #: 2
EC 492 Mr. Joseph Tribble Vol #: 2
EC 493 Ms. Ann Campbell Vol #: 2
EC 494 Mrs. Sharon Harrigan Vol #: 2
EC 495 Mr. Christopher Stier Vol #: 2
EC 496 Mr. David Hill Vol #: 2
EC 497 Dr. Mary Martin Vol #: 2
EC 498 Mrs. Patricia Nevinger Vol #: 2
EC 499 Ms. Paula Ciszewski Vol #: 2
EC 500 ACOG Vol #: 2
EC 501 Ms. Ora Royce Vol #: 2
EC 502 Miss. L Steele Vol #: 2
EC 503 Mr. John Sullivan Vol #: 2
EC 504 Mr. Daniel West Vol #: 2
EC 505 Mr. Phillip Padden Vol #: 2
EC 506 Dr. Janet Shepherd Vol #: 2
EC 507 Mr. Roger McCrady Vol #: 2
EC 508 Mrs. stephanye yadkowski Vol #: 2
EC 509 Ms. Pros Senke Vol #: 2
EC 510 Advanced Women's Care Vol #: 2
EC 511 Dr. Jaime Pham Vol #: 2
2005P-0139 withdrawal of approvals of certain herdwide/flockwide uses of critically and highly important antibiotics pursuant to guidance #152
EMC 766 B Birdsey Vol #: 3
2005P-0267 Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
EC 96 NYU School of Medicine, Dept. of Anesthesiology Vol #: 2
EC 97 Edward Hospital Vol #: 2
EC 98 First Colonies Anesthesia Associates Vol #: 2
EMC 1 N Trombino Vol #: 2
2005P-0325 Request Commissioner of Food and Drugs to amend its regulations related to sugar and alternative sweeteners
EC 2 Mr. Benjamin Cooper Vol #: 2
2005P-0398 ANDA Suitability for Carboplatin Injection, 10 mg/mL in a 1000 mg/100 mL multiple-dose vial
ACK 1 HFA-305 to Lachman Consultant Services, Inc. Vol #: 1
CP 1 Lachman Consultant Services, Inc. Vol #: 1
2005P-0400 permission to Donna Ricks to contine using Palladone for severe chronic pain due to stage 4 metastic breast cancer
CP 1 Donna Ricks Vol #: 1

Page created on October 12, 2005 RSC

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management